Management & platform partners

International competition accelerates the need for improved and cost-effective production and process facilities.

The establishment of world-class research that enables the development of radically new methods of optimising the processes used by biotech businesses is a precondition for satisfying this need.

BIOPRO’s activities are based on the challenges facing everyday industrial production. The businesses involved are global players in their respective industries. No matter if the end products are industrial enzymes, pharmaceuticals, bio-based energy or food ingredients, the ability to understand and manage production processes is a key parameter with great significance to the ability to compete in the world market.

Chr. Hansen
Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology.
CP Kelco
From the world's largest pectin production plant, located in Lille Skensved, CP Kelco supplies a major share of the pectin and carrageenan used in global food production. Pectin is extracted from citrus peel, while carrageenan is made on the basis of seaweed. The end products are used to provide food, pharmaceuticals etc. the desired texture.

Novo Nordisk
Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 33,900 employees in 75 countries, and markets its products in more than 190 countries. The factories in Kalundborg represent the largest production area in Novo Nordisk, and a substantial amount of the world’s insulin is produced at the site.
Novozymes is a world leader in bioinnovation. Together with customers in a number of industries we create tomorrow's industrial biological solutions to improve our customers' business and the exploitation of the world's resources. With more than 700 products in 130 countries, Novozymes' bioinnovations improve the results of the industry while at the same time securing the world's resources thanks to superior, sustainable solutions to tomorrow's market needs. Novozymes has production facilities several places in the world and the plant in Kalundborg handles the largest and most advanced enzyme production in the world.